New NAFLD/NASH Preclinical Model Data to be Presented at ADA 2020

SAN DIEGO, June 09, 2020 (GLOBE NEWSWIRE) — Crown Bioscience today announced the presentation of new, proprietary NAFLD/NASH preclinical model development data. The data will be available at the American Diabetes Association (ADA) 80th Scientific Sessions, as well as CrownBio’s own complementary virtual event.